Cation-Tolerant Defensin Peptides for Pathogen Resistance
Solution Overview
Problem
Current plant defensins used for antimicrobial purposes often lose efficacy at elevated concentrations of mono- and bivalent cations, limiting their effectiveness in controlling multiple plant pathogens and requiring new modes of action to combat resistant microbes.
Innovation Solution
Development of recombinant and edited polynucleotides encoding cation-tolerant defensin peptides with modified amino acid sequences that maintain antifungal activity across varying ionic conditions, integrated into plant genomes or expressed in transgenic plants to enhance resistance to plant pathogens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current plant defensins are used for antimicrobial purposes, then they can inhibit microbial growth, but they lose efficacy at elevated concentrations of mono- and bivalent cations
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of defensin peptides to alter their chemical properties. Specifically, the invention changes the charge distribution and ionic composition of the peptides through amino acid substitutions, enabling them to maintain antimicrobial activity across a broader range of ionic conditions including elevated concentrations of mono- and bivalent cations.
Solution Approach 2:
The patent creates composite antimicrobial peptides by combining defensin sequences with other peptide components or modifying existing defensins with additional functional elements. These composite structures integrate the antimicrobial activity of defensins with enhanced ionic tolerance properties, allowing the peptides to function effectively in diverse physiological environments with varying salt concentrations.
2Reliability
If existing antimicrobial agents are used to control plant pathogens, then they can provide protection against specific microbes, but plant pathogenic microbes can become resistant to these agents
Solution Approach 1:
The patent applies dynamics by creating a library of defensin peptide variants with different amino acid sequences and properties. This dynamic approach allows selection of appropriate peptide variants based on the specific pathogen threat and environmental conditions, preventing microbes from developing resistance to a single static antimicrobial agent. The system can adapt by deploying different peptide variants as needed.
Solution Approach 2:
The patent achieves universality by designing defensin peptides with broad-spectrum antimicrobial activity against multiple plant pathogenic microbes including fungi, oomycetes, and bacteria. The modified defensins maintain effectiveness against diverse pathogens while tolerating varying ionic conditions, making them versatile control agents that can address multiple threats simultaneously and reduce the risk of resistance development through varied modes of action.
3Reliability
If recombinant and edited polynucleotides encoding modified defensin peptides are integrated into plant genomes, then transgenic plants can be enhanced for resistance to plant pathogens, but the complexity of development and regulation increases
Solution Approach 1:
The patent applies segmentation by dividing the defensin peptide into modular sequence elements including conserved regions and variable regions. This modular structure allows for systematic genetic modification where specific segments can be altered, deleted, or replaced to optimize ionic tolerance and antimicrobial activity. The segmented approach simplifies the genetic engineering process by enabling targeted modifications rather than requiring complete redesign of the peptide sequence.
Data Source
AI summary
Antimicrobial OeDef1-, MtDef6-, or OeDef7-type peptides and proteins are disclosed along with compositions comprising the OeDef1-, MtDef6-, or OeDef7-type peptides and proteins and transgenic or genetically edited plants or microorganisms that express the OeDef1-, MtDef6-, or OeDef7-type peptides and proteins to inhibit growth of pathogenic microbes. Such OeDef1-, Mt-Def6-, or OeDef7-type peptides and proteins, compositions, plants, and microorganisms can provide for inhibition of microbial growth.